Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — Long-term Investment Intensity
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a Long-term Investment Intensity of 0.4% as of December 2019. Long-term investments of $16.37 Million represent 0.4% of total assets of $3.67 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how aggressively does Amneal Pharmaceuticals, Inc. Class A Com reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Amneal Pharmaceuticals, Inc. Class A Common Stock Long-term Investment Intensity (2019–2019)
This chart shows how Amneal Pharmaceuticals, Inc. Class A Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2019 to 2019. As of December 2019, the intensity stands at 0.4%, reflecting long-term investments of $16.37 Million against total assets of $3.67 Billion USD. Explore AMRX debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Amneal Pharmaceuticals, Inc. Class A Common Stock (2019–2019)
The table below presents the year-by-year Long-term Investment Intensity for Amneal Pharmaceuticals, Inc. Class A Common Stock from 2019 to 2019, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Amneal Pharmaceuticals, Inc. Class A Com market cap and net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 0.4% | $16.37 Million | $3.67 Billion | — |